← Leaderboards
Aaron Aponick
Stanford University
$1,287,779
Attributed
$1,287,779
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $294.1K · FY2005–25$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,287,779 · 2
By mechanism
R01$1,171,481 · 1
F32$116,298 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Philip C Hanawalt$11,627,777
- Alison J Frontier$2,654,634
- Eric T. Kool$24,920,252
- John Brannon Gary$149,610
- Magdalena Murray$85,500
Others in their field
Top investigators on “Nitrogen”
- David Heimbrook · Leidos Biomedical Research, Inc.$101,524,018
- Anita L Lopez · University Of Hawaii$59,384,372
- Robert O Wright · Brigham And Women'S Hospital$33,600,055
- Rosalind J Wright · Icahn School Of Medicine At Mount Sinai$31,836,207
- Stephen L Buchwald · Massachusetts Institute Of Technology$19,106,380
- Debra Lynn Laskin · Rutgers Biomedical And Health Sciences$18,759,355
Research focus
NitrogenImidazoleCharacteristicsAlkynesEnantiomer3-DimensionalAcademiaAldehydesBehaviorBiologyAminesCarbonCatalysisCatalystDesignAreaChemistryChiral MoleculeCollectionComplexCopperCouplingBiotechnologyElements
Grant awards (7)
Development of Strategies for the Enantioselective Synthesis of Heterocycles and Acyclic Amines$293,023
R01 · FY2025 · GM · contact PI
Development of Strategies for the Enantioselective Synthesis of Heterocycles and Acyclic Amines$292,089
R01 · FY2024 · GM · contact PI
Development of Strategies for the Enantioselective Synthesis of Heterocycles and Acyclic Amines$292,259
R01 · FY2023 · GM · contact PI
Development of Strategies for the Enantioselective Synthesis of Heterocycles and Acyclic Amines$294,110
R01 · FY2022 · GM · contact PI
A General Synthetic Route to Glycosidase Inhibitors$32,622
F32 · FY2006 · GM · contact PI
A General Synthetic Route to Glycosidase Inhibitors$43,976
F32 · FY2005 · GM
A General Synthetic Route to Glycosidase Inhibitors$39,700
F32 · FY2003 · GM